Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 10,000 shares at $32.30 ($324K) on 2021-10-06, disclosed to the SEC on 2021-10-07.
Open-market sale of $324k ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.51 | 5,000 | $163K | 50.2% |
| 2 | $32.30 | 5,000 | $162K | 49.8% |
| Total | $32.41 avg | 10,000 | $324K | 100% |
| Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |
| ADPT | SELL | 2021-07-08 | $1.2M | — | Filing → |